Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

• click to rate

  Posted by Two Blokes Jul 17 - Filed in Stock - 3 views
  
  WHO WHAT WHEN WHY Nuwellis, Inc. Termination of theREVERSE-HF clinicaltrial July 17, 2025 To redirect resources towardoutpatient markets where scalableimpact is highest.   MINNEAPOLIS, July 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. today announced the termination of its REVERSE-HF clinical trial, a randomized post-market trial evaluating ultrafiltration vs.